A cancer diagnosis is devastating. A diagnosis of stage IV cancer is even worse. The prognosis of primary peritoneal cancer is not great, but it's manageable. This cancer mimicking ovarian cancer who have few symptoms until it is quite advanced. Standard treatments include surgery and chemotherapy.
There are other forms of cancer, advanced seem to hide or misdiagnosed because they are growing. One thing is for GIST Gastrointestinal StromaTumor. Just a few years ago, the diagnosis of this tumor gastric mucosa sufficient to start the funeral. But this is not the case. Advances in research and in the separation of fact this type of cancer from other types of cancer, cancer that were all thrown into a pot category in the stomach, the diagnosis of GIST is no longer an immediate death sentence.
A few drugs on the market made a big difference. One is called Gleevec and the other is called Sutent.Glivec is usually the first line of defense. This drug is an inhibitor of protein that the tumor will shrink and attacks. It has a success rate of 70%, cancer is unheard of for most types.
Interestingly, it was first used in the treatment of leukemia and was developed by a doctor as a last ditch effort for a patient who was dying in GIST used. Now is the standard protocol for the treatment of GIST.
Glivec is not without side effects, but more manageable. One of these is short termMemory loss. This is not a big problem for you in line at the post office and can not remember where the package is your mailing will go.
Prognosis of primary peritoneal cancer will be more favorable as other cancer drugs developed to treat this particular type. Research is in progress and discoveries are made all the time.
No comments:
Post a Comment